Alpha-galactosidase A (GLA) Antibody

299€ (50 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Alpha-galactosidase A (GLA) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx402532
tested applications
ELISA, IHC, FCM
Description
Alpha-galactosidase A (GLA) Antibody is a Recombinant Rabbit Monoclonal antibody for the detection of Human GLA.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Alpha-galactosidase A (GLA) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | IHC: 1/50 - 1/200, FCM: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Monoclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Expression | Recombinant |
Purification | Purified by affinity chromatography. |
Size 1 | 50 µl |
Size 2 | 100 µl |
Form | Liquid |
Tested Applications | ELISA, IHC, FCM |
Buffer | PBS, pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | P06280 |
Background | Antibody anti-GLA |
Status | RUO |
Descripción
Related Products

Human GLA (Alpha-galactosidase A) ELISA Kit
Ver Producto
Porcine GLA (Alpha-galactosidase A) ELISA Kit
Ver Producto
GLA antibody
GLA, also named as Melibiase, Agalsidas and Alpha-galactosidase A, Belongs to the glycosyl hydrolase 27 family. It hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-D-galactosides, including galactose oligosaccharides, galactomannans and galactolipids. Fabry disease is an X-linked lysosomal storage disorder resulting from the deficient activity of GLA. Enzyme replacement therapy(ERT) with GLA is currently the most effective therapeutic strategy for patients with Fabry disease, a lysosomal storage disease.
Ver Producto